Delivery Order SPE2DR25D1109-SPE2DR26FFG6F
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,152.60 to AmerisourceBergen Drug Corp for the supply of Tresiba FlexTouch 100 Unit/ML in 3ML quantities. This is a firm fixed price, competitively awarded contract with no set-aside designation. The delivery order was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $41,658.25 to supply Tresiba FlexTouch 100 Unit/mL in 3mL quantities. The award was made on September 17, 2025, with an ultimate completion date of September 18, 2025, under a firm fixed-price contract with no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Tresiba FlexTouch 200 units/mL in 3mL quantities, valued at $11,182.92 under a firm fixed-price contract structure. This non-set-aside competitive award is positioned to be completed by June 3, 2025, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a procurement of insulin medication to support federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Tresiba FlexTouch 100 Unit/mL 3mL insulin pens, with a ceiling value of $3,111.48. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for ultimate completion on November 17, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $5,974.46 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 200 units/mL in 3mL quantities. This is a firm fixed price delivery order with no set-aside designation, competitively awarded and due for completion by November 17, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Tresiba FlexTouch 100 Unit/mL 3mL insulin pens, with a ceiling value of $3,781.10. This non-competitive delivery order utilizes firm fixed pricing and is scheduled for completion by November 19, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $4,019.90 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 200 Unit/mL 3mL insulin pens. This non-competitive, firm fixed price delivery order was awarded on November 14, 2025, with an ultimate completion date of November 17, 2025. The order will be fulfilled at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,737.07 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 200 unit/mL 3mL insulin pens on August 12, 2025, with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a $4,152.30 delivery order to AmerisourceBergen Drug Corp for Tresiba FlexTouch 200 Unit/ML 3ML insulin pens on July 21, 2025, with completion scheduled for July 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- This is a $23,508.27 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4,565,362,864 units of Tresiba FlexTouch 100 unit/mL 3mL, a prescription insulin product, with a performance period through August 7, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFG6FDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Tresiba FlexTouch 200 units/mL in 3mL quantities, with a ceiling value of $3,467.02 and a completion date of November 19, 2025. This is a firm fixed price delivery order issued without set-aside designation, reflecting open competition. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Tresiba is a diabetes medication, consistent with AmerisourceBergen's extensive portfolio of specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains, supporting Defense Health Agency customers and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 11/18/25 |